Trademarkia Logo

United Kingdom

£
Trademark Search
Myricx Bio

View On IPO.GOV.UK

Application Published

on 28 Feb 2025

Last Applicant/ Owned by

Myricx Pharma Limited

London Innovation Centre, 20 Water Street, Canary Wharf

London, , E14 5GX

Serial Number

UK00004166932 filed on 28th Feb 2025

Correspondent Information

Penningtons Manches Cooper LLP

9400 Garsington Road, Oxford Business Park

Oxford,

OX4 2HN

Myricx Bio

pharmaceutical and biotechnological preparations; pharmaceutical and biotechnological preparations for the diagnosis and treatment of human diseases; Read More

Classification Information

Class [5]
Pharmaceutical Products

Pharmaceutical and biotechnological preparations; pharmaceutical and biotechnological preparations for the diagnosis and treatment of human diseases; pharmaceutical and biotechnological preparations for the diagnosis and treatment of proliferative human diseases; pharmaceutical and biotechnological preparations for the diagnosis and treatment of diseases including cancer, fibrosis, inflammation, senescence and diseases of aging; antibody drug conjugates (ADCs); antibody drug conjugates (ADCs) for the diagnosis and treatment of human diseases; antibody drug conjugates (ADCs) for the diagnosis and treatment of proliferative human diseases; antibody drug conjugates (ADCs) for the diagnosis and treatment of diseases including cancer, fibrosis, inflammation, senescence and diseases of aging; N-myristoyltransferases (NMT) inhibitors; N-myristoyltransferases (NMT) inhibitors for the diagnosis and treatment of human diseases; N-myristoyltransferases (NMT) inhibitors for the diagnosis and treatment of proliferative human diseases; N-myristoyltransferases (NMT) inhibitors for the diagnosis and treatment of diseases including cancer, fibrosis, inflammation, senescence and diseases of aging.

Class [42]
Computer & Software Services & Scientific Services

Scientific and biomedical research; scientific and biomedical research in the field of human diseases; scientific and biomedical research in the field of proliferative human diseases; scientific and biomedical research in the field of diseases including cancer, fibrosis, inflammation, senescence and diseases of aging; development, testing and commercialisation of pharmaceuticals and biotechnological preparations; development, testing and commercialisation of pharmaceuticals and biotechnological preparations for the diagnosis and treatment of human diseases; development, testing and commercialisation of pharmaceuticals and biotechnological preparations for the diagnosis and treatment of proliferative human diseases; development, testing and commercialisation of pharmaceuticals and biotechnological preparations for the diagnosis and treatment of diseases including cancer, fibrosis, inflammation, senescence and diseases of aging; development, testing and commercialisation of antibody drug conjugates (ADCs) and N-myristoyltransferases (NMT) inhibitors; consultancy, advisory and information services relating to the aforesaid services.

Mark Details

Serial Number

UK00004166932

Mark Type

Figurative

Kind of mark

Individual